TSL2109 Capsules in Advanced Solid Tumor Patients: Safety, Tolerability, PK and Preliminary Efficacy

Clinical trial NCT07514065 · RECRUITING

Trial details

NCT number: NCT07514065
Sponsor: Tasly Pharmaceutical Group Co., Ltd
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Castration-Resistant Prostate Cancer Patients

Start date: 2026-02-20
Primary completion: 2026-12-31
Enrollment: 78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.